Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies

NCT03682029 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
Chronic Myelomonocytic Leukemia-1
Cytopenia

Interventions

DIETARY_SUPPLEMENT: Vitamin C (ascorbic acid)
OTHER: Placebo

Sponsor

Rigshospitalet, Denmark

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]